Development costs (IFRS)

The YoungLife AG developed a new method for measuring the UV-radiation emitted by the sunbeds produced during the financial year. Until the grant of the patent, capitalizable expenses of EUR 500.000 had been incurred. The European Patent Office granted the patent for exactly tenyears, because the benefit could be proven through the patent. When the patent was granted, the managing director, Mr. Herbst, received offers from two companies in the amount of EUR 1,2 million for the purchase of the patent.